IART Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $418.76M; Cost of revenue $199.02M; Research and development (m); Selling, general and administrative $172.44M.
- 2026-03-31: Revenue $391.92M; Cost of revenue $174.94M; Research and development (m); Selling, general and administrative $178.24M.
- 2025-12-31: Revenue $434.93M*; Cost of revenue $214.06M*; Research and development (m); Selling, general and administrative $169.27M*.
- 2025-09-30: Revenue $402.06M; Cost of revenue $195.07M; Research and development (m); Selling, general and administrative $169.05M.
Consolidation item
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Geography
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $418.76M | $199.02M | (m) | $172.44M | $262.00K | $4.48M |
| 2026-03-31 | $391.92M | $174.94M | (m) | $178.24M | $2.21M | -$4.62M |
| 2025-12-31 | $434.93M* | $214.06M* | (m) | $169.27M* | $6.01M* | -$2.03M* |
| 2025-09-30 | $402.06M | $195.07M | (m) | $169.05M | -$1.42M | -$5.40M |
| 2025-06-30 | $415.61M | $206.27M | (m) | $179.89M | -$46.88M | -$484.07M |
| 2025-03-31 | $382.65M | $188.22M | (m) | $181.50M | -$4.74M | -$25.29M |
| 2024-09-30 | $380.83M | $180.60M | (m) | $177.19M | -$9.67M | -$10.70M |
| 2024-06-30 | $418.18M | $192.26M | (m) | $195.47M | -$2.78M | -$12.40M |
| 2024-03-31 | $368.87M | $162.04M | (m) | $165.80M | -$1.95M | -$3.28M |
| 2023-09-30 | $382.42M | $164.08M | (m) | $161.95M | -$888.00K | $19.50M |
| 2023-06-30 | $381.27M | $174.24M | (m) | $164.91M | -$360.00K | $4.18M |
| 2023-03-31 | $380.85M | $147.97M | (m) | $166.66M | $5.55M | $24.23M |
| 2022-09-30 | $385.19M | $148.44M | (m) | $143.82M | $8.88M | $49.91M |
| 2022-06-30 | $397.81M | $148.40M | (m) | $160.65M | $6.79M | $44.79M |
| 2022-03-31 | $376.64M | $142.57M | (m) | $159.93M | $6.41M | $32.90M |
| 2021-09-30 | $386.86M | $144.47M | (m) | $156.01M | $7.56M | $43.23M |
| 2021-06-30 | $389.99M | $151.27M | (m) | $162.55M | $9.76M | $35.07M |
| 2021-03-31 | $360.07M | $145.82M | (m) | $156.63M | $21.88M | $45.39M |
| 2020-12-31 | $388.65M | (m) | (m) | (m) | (m) | $92.74M |
| 2020-09-30 | $370.23M | $134.81M | (m) | $150.08M | $9.17M | $32.34M |
| 2020-06-30 | $258.67M | $105.48M | $14.93M | $116.11M | $2.02M | -$369.00K |
| 2020-03-31 | $354.32M | $133.48M | $20.82M | $165.95M | $2.26M | $9.18M |
| 2019-12-31 | $395.13M | (m) | (m) | (m) | (m) | $15.32M |
| 2019-09-30 | $379.10M | $142.64M | $19.00M | $173.10M | $101.00K | -$27.61M |
| 2019-06-30 | $383.64M | $143.67M | $17.63M | $165.38M | $6.65M | $29.74M |
| 2019-03-31 | $359.69M | $128.91M | $18.32M | $174.87M | -$7.93M | $32.76M |
| 2018-12-31 | $383.31M | (m) | (m) | (m) | (m) | $25.14M |
| 2018-09-30 | $365.85M | $143.25M | $20.31M | $173.35M | -$2.27M | $13.29M |
| 2018-06-30 | $366.19M | $137.56M | $19.11M | $176.60M | $1.35M | $11.38M |
| 2018-03-31 | $357.08M | $144.22M | $18.32M | $163.57M | -$1.86M | $10.99M |
| 2017-12-31 | $368.60M | (m) | (m) | (m) | (m) | $44.35M |
| 2017-09-30 | $278.83M | $101.76M | $15.03M | $145.94M | $76.00K | $3.16M |
| 2017-06-30 | $282.16M | $99.00M | $15.75M | $145.01M | -$2.83M | $10.84M |
| 2017-03-31 | $258.64M | (m) | $15.49M | $142.50M | -$1.65M | $6.39M |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $28.25M |
| 2016-09-30 | $250.33M | (m) | $15.12M | $112.32M | $4.85M | $20.14M |
| 2016-06-30 | $249.31M | (m) | $14.68M | $119.22M | $2.19M | $12.76M |
| 2016-03-31 | $236.77M | (m) | $14.45M | $111.97M | $1.58M | $13.42M |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | $14.98M |
| 2015-09-30 | $226.37M | (m) | $13.94M | $113.42M | $37.24M | -$31.88M |
| 2015-06-30 | $212.67M | (m) | $12.01M | $99.32M | $5.99M | $5.00M |
| 2015-03-31 | $202.53M | (m) | $11.08M | $93.27M | $6.06M | $8.38M |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $17.17M |
| 2014-09-30 | $197.52M | (m) | $11.13M | $93.79M | $1.97M | $9.81M |
| 2014-06-30 | $231.35M | (m) | $13.74M | $115.25M | $2.36M | $4.83M |
| 2014-03-31 | $215.06M | (m) | $12.57M | $108.34M | $1.77M | $2.21M |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | $13.77M |
| 2013-09-30 | $213.25M | (m) | $13.05M | $99.79M | -$6.35M | -$30.33M |
| 2013-06-30 | $205.55M | (m) | $11.81M | $103.28M | -$947.00K | $1.52M |
| 2013-03-31 | $196.65M | (m) | $12.72M | $102.96M | -$1.87M | -$6.03M |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | $12.79M |
| 2012-09-30 | $210.08M | (m) | $13.11M | $93.08M | $1.04M | $13.21M |
| 2012-06-30 | (m) | (m) | $13.13M | $96.10M | $3.06M | $8.51M |
| 2012-03-31 | (m) | (m) | $11.91M | $87.41M | $2.90M | $6.69M |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | $4.56M |
| 2011-09-30 | (m) | (m) | $13.19M | $87.51M | $44.00K | $11.24M |
| 2011-06-30 | (m) | (m) | $12.71M | $95.73M | $1.30M | $699.00K |
| 2011-03-31 | (m) | (m) | $12.15M | $80.08M | $3.35M | $11.49M |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | $18.81M |
| 2010-09-30 | (m) | (m) | $11.72M | $75.74M | $5.79M | $16.48M |
| 2010-06-30 | (m) | (m) | $11.76M | $74.22M | $5.94M | $15.16M |
| 2010-03-31 | (m) | (m) | $11.30M | $72.51M | $4.09M | $15.22M |
| 2009-09-30 | (m) | (m) | $11.53M | $69.92M | $3.71M | $14.43M |
| 2009-06-30 | (m) | (m) | $10.30M | $68.25M | $6.16M | $11.22M |
Revenue and expense 6 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $810.68M | $373.95M | (m) | $350.67M | $2.47M | -$134.00K |
| 2025-06-30 | $798.26M | $394.49M | (m) | $361.39M | -$51.62M | -$509.37M |
| 2024-06-30 | $787.05M | $354.30M | (m) | $361.27M | -$4.73M | -$15.68M |
| 2023-06-30 | $762.11M | $322.22M | (m) | $331.56M | $5.19M | $28.41M |
| 2022-06-30 | $774.45M | $290.97M | (m) | $320.58M | $13.20M | $77.69M |
| 2021-06-30 | $750.06M | $297.09M | (m) | $319.19M | $31.64M | $80.46M |
| 2020-06-30 | $612.99M | $238.95M | $35.74M | $282.06M | $4.28M | $8.81M |
| 2019-06-30 | $743.34M | $272.58M | $35.95M | $340.25M | -$1.29M | $62.49M |
| 2018-06-30 | $723.27M | $281.79M | $37.43M | $340.16M | -$505.00K | $22.37M |
| 2017-06-30 | $540.80M | $185.58M | $31.24M | $287.51M | -$4.48M | $17.23M |
| 2016-06-30 | $486.08M | (m) | $29.13M | $231.19M | $3.76M | $26.17M |
| 2015-06-30 | $415.21M | (m) | $23.09M | $192.58M | $12.05M | $13.38M |
| 2014-06-30 | $446.41M | (m) | $26.31M | $223.59M | $4.13M | $7.03M |
| 2013-06-30 | $402.20M | (m) | $24.52M | $206.24M | -$2.82M | -$4.51M |
| 2012-06-30 | (m) | (m) | $25.04M | $183.51M | $5.96M | $15.21M |
| 2011-06-30 | (m) | (m) | $24.86M | $175.82M | $4.64M | $12.19M |
| 2010-06-30 | (m) | (m) | $23.06M | $146.73M | $10.02M | $30.38M |
| 2009-06-30 | (m) | (m) | $20.95M | $134.70M | $11.54M | $20.79M |
Revenue and expense 9 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-09-30 | $1.20B | $589.57M | (m) | $530.43M | -$53.04M | -$514.77M |
| 2024-09-30 | $1.17B | $534.89M | (m) | $538.46M | -$14.40M | -$26.38M |
| 2023-09-30 | $1.14B | $486.29M | (m) | $493.51M | $4.30M | $47.91M |
| 2022-09-30 | $1.16B | $439.42M | (m) | $464.40M | $22.08M | $127.60M |
| 2021-09-30 | $1.14B | $441.56M | (m) | $475.19M | $39.20M | $123.69M |
| 2020-09-30 | $983.22M | $373.76M | (m) | $432.14M | $13.46M | $41.15M |
| 2019-09-30 | $1.12B | $415.22M | $53.28M | $513.35M | -$1.19M | $34.88M |
| 2018-09-30 | $1.09B | $425.03M | $57.74M | $513.52M | -$2.78M | $35.66M |
| 2017-09-30 | $819.63M | $287.34M | $46.27M | $433.46M | -$4.41M | $20.39M |
| 2016-09-30 | $736.41M | (m) | $44.25M | $343.51M | $8.62M | $46.32M |
| 2015-09-30 | $641.57M | (m) | $37.03M | $306.01M | $49.29M | -$18.50M |
| 2014-09-30 | $577.64M | (m) | $33.55M | $283.06M | $6.29M | $16.84M |
| 2013-09-30 | $615.45M | (m) | $37.58M | $306.04M | -$9.17M | -$34.84M |
| 2012-09-30 | $616.44M | (m) | $38.15M | $276.58M | $7.00M | $28.42M |
| 2011-09-30 | (m) | (m) | $38.05M | $263.32M | $4.69M | $23.43M |
| 2010-09-30 | (m) | (m) | $34.78M | $222.47M | $15.81M | $46.86M |
| 2009-09-30 | (m) | (m) | $32.47M | $204.62M | $15.25M | $35.22M |
Revenue and expense 12 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.64B | $803.63M | (m) | $699.70M | -$47.03M | -$516.80M |
| 2024-12-31 | $1.61B | $728.47M | (m) | $716.98M | -$11.29M | -$6.90M |
| 2023-12-31 | $1.54B | $656.84M | (m) | $656.64M | $13.33M | $67.70M |
| 2022-12-31 | $1.56B | $587.36M | (m) | $616.32M | $33.34M | $180.60M |
| 2021-12-31 | $1.54B | $597.81M | (m) | $637.45M | $45.60M | $169.10M |
| 2020-12-31 | $1.37B | $520.83M | (m) | $594.53M | -$40.37M | $133.89M |
| 2019-12-31 | $1.52B | $564.68M | (m) | $687.60M | $9.90M | $50.20M |
| 2018-12-31 | $1.47B | $571.50M | $78.04M | $690.75M | -$3.40M | $60.80M |
| 2017-12-31 | $1.19B | $435.51M | $63.45M | $624.10M | -$53.36M | $64.74M |
| 2016-12-31 | $992.08M | $349.09M | $58.16M | $455.63M | $15.84M | $74.56M |
| 2015-12-31 | (m) | (m) | $50.90M | $415.76M | $53.82M | -$3.52M |
| 2014-12-31 | (m) | (m) | $43.56M | $375.55M | $9.27M | $34.00M |
| 2013-12-31 | (m) | (m) | $42.62M | $332.19M | -$3.24M | -$21.07M |
| 2012-12-31 | (m) | (m) | $51.01M | $373.11M | $10.82M | $41.20M |
| 2011-12-31 | (m) | (m) | $51.45M | $358.13M | $505.00K | $27.99M |
| 2010-12-31 | (m) | (m) | $48.11M | $305.06M | $16.45M | $65.67M |
| 2009-12-31 | (m) | (m) | $44.28M | $281.10M | $22.20M | $50.95M |
| 2008-12-31 | (m) | (m) | $60.49M | $281.00M | -$9.19M | $27.73M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |